MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 534933 | Name: Fodipir
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Fodipir is the ligand part in the molecule mangafodipir and is a useful precusor to make mangafodipir. Fodipir is the pharmacologically active part in the structure of mangafodipir, which prevents 7β-OH-induced cell death by attenuating cellular ROS and by preventing LMP. In addition, MnPLED, which is the dephosphorylated product of fodipir, exerts a similar protective effect against 7β-OH-induced cytotoxicity. Study showed that fodipir (DPDP) binds neurotoxic Pt2+ with a high affinity.

Chemical Structure

Fodipir
Fodipir
CAS#118248-91-2

Theoretical Analysis

MedKoo Cat#: 534933

Name: Fodipir

CAS#: 118248-91-2

Chemical Formula: C22H32N4O14P2

Exact Mass: 638.1390

Molecular Weight: 638.46

Elemental Analysis: C, 41.39; H, 5.05; N, 8.78; O, 35.08; P, 9.70

Price and Availability

Size Price Availability Quantity
10mg USD 350.00 2 Weeks
25mg USD 650.00 2 Weeks
50mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Fodipir; DPDP; NSC766818; NSC 766818; NSC-766818
IUPAC/Chemical Name
Glycine, N,N'-1,2-ethanediylbis(N-((3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)-
InChi Key
SQKUFYLUXROIFM-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H32N4O14P2/c1-13-21(31)17(15(5-23-13)11-39-41(33,34)35)7-25(9-19(27)28)3-4-26(10-20(29)30)8-18-16(12-40-42(36,37)38)6-24-14(2)22(18)32/h5-6,31-32H,3-4,7-12H2,1-2H3,(H,27,28)(H,29,30)(H2,33,34,35)(H2,36,37,38)
SMILES Code
O=C(O)CN(CCN(CC1=C(O)C(C)=NC=C1COP(O)(O)=O)CC(O)=O)CC2=C(O)C(C)=NC=C2COP(O)(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 638.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Abdel-Aziz AA, Al-Badr AA, Hafez GA. Flurbiprofen. Profiles Drug Subst Excip Relat Methodol. 2012;37:113-81. doi: 10.1016/B978-0-12-397220-0.00004-0. Epub 2012 Mar 19. PMID: 22469318. 2: Flurbiprofen. Med Lett Drugs Ther. 1989 Apr 7;31(789):31-2. PMID: 2648127. 3: DeLia JE, Emery MG, Taylor RH, Scott JR. Flurbiprofen in dysmenorrhea. Clin Pharmacol Ther. 1982 Jul;32(1):76-80. doi: 10.1038/clpt.1982.129. PMID: 7083734. 4: Richy F, Rabenda V, Mawet A, Reginster JY. Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative. Int J Clin Pract. 2007 Aug;61(8):1396-406. doi: 10.1111/j.1742-1241.2007.01452.x. Epub 2007 Jun 26. PMID: 17596188. 5: Gulen M, Unver Koluman B, Avci A, Satar S. Flurbiprofen-Associated Hemolytic Anemia. Am J Ther. 2019 Nov/Dec;26(6):e723-e726. doi: 10.1097/MJT.0000000000000879. PMID: 30418224. 6: Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin Pharmacokinet. 1995 Feb;28(2):100-14. doi: 10.2165/00003088-199528020-00002. PMID: 7736686. 7: Kaiser DG, Brooks CD, Lomen PL. Pharmacokinetics of flurbiprofen. Am J Med. 1986 Mar 24;80(3A):10-5. doi: 10.1016/0002-9343(86)90104-x. PMID: 3963013. 8: Zhang L, Zhu J, Xu L, Zhang X, Wang H, Luo Z, Zhao Y, Yu Y, Zhang Y, Shi H, Bao H. Efficacy and safety of flurbiprofen axetil in the prevention of pain on propofol injection: a systematic review and meta-analysis. Med Sci Monit. 2014 Jun 17;20:995-1002. doi: 10.12659/MSM.890102. PMID: 24935068; PMCID: PMC4070992. 9: Zhang L, Xie J, Liu C, Sun Y, Zhang P. Comparison of percutaneous permeation profiles of flurbiprofen enantiomers. Chirality. 2022 Jun;34(6):894-900. doi: 10.1002/chir.23441. Epub 2022 Apr 12. PMID: 35411968. 10: Geerts H. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease. IDrugs. 2007 Feb;10(2):121-33. PMID: 17285465. 11: Brogden RN, Heel RC, Speight TM, Avery GS. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001. PMID: 391529. 12: Solomon GD, Kunkel RS. Flurbiprofen in the prophylaxis of migraine. Cleve Clin J Med. 1993 Jan-Feb;60(1):43-8. doi: 10.3949/ccjm.60.1.43. PMID: 8443934. 13: AlSalem HS, Monier M, Abomuti MA, Alnoman RB, Alharbi HY, Aljohani MS, Al- Goul ST, Elkaeed EB, Zghab I, Shafik AL. Chiral resolution of (±)-flurbiprofen using molecularly imprinted hydrazidine-modified cellulose microparticles. Int J Biol Macromol. 2023 Dec 31;253(Pt 4):126928. doi: 10.1016/j.ijbiomac.2023.126928. Epub 2023 Sep 17. PMID: 37717875. 14: Gasparini L, Ongini E, Wilcock D, Morgan D. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease. Brain Res Brain Res Rev. 2005 Apr;48(2):400-8. doi: 10.1016/j.brainresrev.2004.12.029. Epub 2005 Jan 28. PMID: 15850679. 15: Huskisson EC, Scott PJ, Boyle S, Patrick M. Flurbiprofen at night. Curr Med Res Opin. 1977;5(1):85-7. doi: 10.1185/03007997709108982. PMID: 71974. 16: Cui X, Ding Q, Shan RN, He CH, Wu KJ. Enantioseparation of flurbiprofen enantiomers using chiral ionic liquids by liquid-liquid extraction. Chirality. 2019 Jun;31(6):457-467. doi: 10.1002/chir.23071. Epub 2019 May 7. PMID: 31062890. 17: Paliwal S, Tilak A, Sharma J, Dave V, Sharma S, Yadav R, Patel S, Verma K, Tak K. Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model. Lipids Health Dis. 2019 Jun 7;18(1):133. doi: 10.1186/s12944-019-1064-x. PMID: 31170970; PMCID: PMC6554971. 18: Wang RD, Sheng XR, Guan WX, Wang M, Peng C, Yang YY, Huang HG, Ning-Li, Jia WD. Flurbiprofen axetil for postoperative analgesia in upper abdominal surgery: a randomized, parallel controlled, double-blind, multicenter clinical study. Surg Today. 2020 Jul;50(7):749-756. doi: 10.1007/s00595-019-01951-1. Epub 2020 Jan 10. PMID: 31925579. 19: Yi EM, Leech E. Topical flurbiprofen toxicosis in a cat. J Vet Emerg Crit Care (San Antonio). 2017 Nov;27(6):707-712. doi: 10.1111/vec.12638. Epub 2017 Aug 23. PMID: 28834579. 20: Kaufhold J, Wilkowski M, McCabe K. Flurbiprofen-associated acute tubulointerstitial nephritis. Am J Nephrol. 1991;11(2):144-6. doi: 10.1159/000168291. PMID: 1951476.